Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine

PaperCitations, authors & open-access status

Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 1,249 citations, 2020 year and green oa status.

1,249
Citations
2020
Year
green
OA Status

Related on ScholarIQ

Nita Patel
Author
New England Journal of Medicine
Journal
SARS-CoV-2 and COVID-19 Research
Topic
SARS-CoV-2 and COVID-19 Research
Topic
vaccines and immunoinformatics approaches
Topic
SARS-CoV-2 detection and testing
Topic
470M+ articles · free account